Insomnia News and Research RSS Feed - Insomnia News and Research

Insomnia is too little or poor-quality sleep caused by one or more of the following:

Trouble falling asleep
Waking up a lot during the night with trouble returning to sleep
Waking up too early in the morning
Having un-refreshing sleep (not feeling well rested), even after sleeping 7 to 8 hours at night

Insomnia can cause problems during the day, such as excessive sleepiness, fatigue, trouble thinking clearly or staying focused, or feeling depressed or irritable. It is not defined by the number of hours you sleep every night. Although the amount of sleep a person needs varies, most people need between 7 and 8 hours of sleep a night.
Genetic variants associated with preference to mornings or nights

Genetic variants associated with preference to mornings or nights

23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person. [More]
Anticholinergic medications may not be best option for dementia patients in rehab facility

Anticholinergic medications may not be best option for dementia patients in rehab facility

During rehabilitation following an acute hospital stay, medications that block neurotransmitters may be overprescribed to older patients suffering from delirium superimposed on dementia, according to health researchers. [More]
Reclaim Your Sleep survey: 46% of female patients waiting over five years to be diagnosed with sleep apnoea

Reclaim Your Sleep survey: 46% of female patients waiting over five years to be diagnosed with sleep apnoea

46% of female patients with sleep apnoea are suffering with sleep problems for over five years before being correctly diagnosed with the condition. [More]
Migraines heat up as women near menopause

Migraines heat up as women near menopause

Migraine headaches heat up as women approach menopause, according to a new study from researchers at the University of Cincinnati, Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research. [More]
AASM officially launches new telemedicine system to increase patient access to sleep medicine

AASM officially launches new telemedicine system to increase patient access to sleep medicine

Today the American Academy of Sleep Medicine officially launched AASM Sleep, a new state-of-the-art telemedicine platform that will dramatically increase patient access to the expertise of board-certified sleep medicine physicians and accredited sleep centers. [More]
Online intervention tool helps rural veteran women suffering from postpartum depression

Online intervention tool helps rural veteran women suffering from postpartum depression

A University of Iowa researcher is working with the Veterans Administration on a pilot program to help female veterans suffering from postpartum depression. [More]
Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015. [More]
Bern study sheds light on the brain mechanism of arousal

Bern study sheds light on the brain mechanism of arousal

Scientists from Bern have discovered a mechanism which is responsible for the rapid arousal from sleep and anesthesia in the brain. The results of their study suggest new strategies for the medical treatment of sleep disorders and recovery of consciousness in vegetative states. [More]
Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study. [More]
New guidelines may help reduce medication use among seniors

New guidelines may help reduce medication use among seniors

We're not getting any younger. According to the Administration for Community Living, by 2060, there will be about 98 million older persons in the United States — more than twice their number in 2013. [More]
New study: Are GPs over prescribing sleeping tablets?

New study: Are GPs over prescribing sleeping tablets?

The team at SleepCogni are dedicated to changing the nations’ sleep habits and conducted an independent study in October 2015 to give a snapshot view of current sleep behaviour. [More]
Specific HRQOL components need to be targeted for achieving optimal care for older cancer patients

Specific HRQOL components need to be targeted for achieving optimal care for older cancer patients

In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients. [More]
Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax Laboratories, Inc. today announced that the European Commission has granted marketing authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease. [More]
Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

In the first prospective study to consider premenstrual syndrome (PMS) as a possible sentinel for future risk of hypertension, epidemiologist Elizabeth Bertone-Johnson and colleagues in the School of Public Health and Health Sciences at the University of Massachusetts Amherst and the Harvard School of Public Health report that women with moderate-to-severe PMS had a 40 percent higher risk of developing high blood pressure over the following 20 years compared to women experiencing few menstrual symptoms. [More]
Atypical antipsychotic shows bipolar I depression efficacy

Atypical antipsychotic shows bipolar I depression efficacy

The atypical antipsychotic cariprazine may be effective for the treatment of bipolar I depression, phase II study findings show. [More]
Traditional Chinese medicine, other nonpharmacological interventions benefit cancer patients

Traditional Chinese medicine, other nonpharmacological interventions benefit cancer patients

A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole, help alleviate depression, fatigue, pain, anxiety, insomnia and gastrointestinal problems in Chinese cancer patients. [More]
Treating insomnia through a CBT device? An interview with Dr Ebrahim

Treating insomnia through a CBT device? An interview with Dr Ebrahim

Insomnia refers to a clinical condition that is characterised by one or more of the following – difficulty initiating sleep and/or maintaining sleep and/or waking up too early AND associated with symptoms the next day such as sleepiness, lethargy, loss of concentration. [More]
Lead exposure in early childhood increases risk for sleep problems in later childhood

Lead exposure in early childhood increases risk for sleep problems in later childhood

A new research study from the University of Pennsylvania School of Nursing shows that lead exposure in early childhood are associated with increased risk for sleep problems and excessive daytime sleepiness in later childhood. [More]
Tai Chi, better sleep quality reduce inflammation, depression and age-related morbidities

Tai Chi, better sleep quality reduce inflammation, depression and age-related morbidities

Inflammatory processes occur throughout the body, with a primary function of promoting healing after injury. However, when too active, these inflammatory processes can also damage the body in many ways, and may contribute to heart disease, stroke, certain cancers, and other significant medical problems. [More]
Sleepwalkers don't feel pain while suffering injuries

Sleepwalkers don't feel pain while suffering injuries

A new study of sleepwalkers found an intriguing paradox: Although sleepwalkers have an increased risk for headaches and migraines while awake, during sleepwalking episodes they are unlikely to feel pain even while suffering an injury. [More]
Advertisement
Advertisement